Citation Formats
Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. EDİGER Et Al. , "Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?," ASTIM ALLERJI IMMUNOLOJI , vol.8, no.3, pp.150-156, 2010

EDİGER, D. Et Al. 2010. Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?. ASTIM ALLERJI IMMUNOLOJI , vol.8, no.3 , 150-156.

EDİGER, D., Yilmaz, D., COŞKUN, N. F., & Gozu, O., (2010). Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?. ASTIM ALLERJI IMMUNOLOJI , vol.8, no.3, 150-156.

EDİGER, DANE Et Al. "Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?," ASTIM ALLERJI IMMUNOLOJI , vol.8, no.3, 150-156, 2010

EDİGER, DANE Et Al. "Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?." ASTIM ALLERJI IMMUNOLOJI , vol.8, no.3, pp.150-156, 2010

EDİGER, D. Et Al. (2010) . "Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?." ASTIM ALLERJI IMMUNOLOJI , vol.8, no.3, pp.150-156.

@article{article, author={DANE EDİGER Et Al. }, title={Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?}, journal={ASTIM ALLERJI IMMUNOLOJI}, year=2010, pages={150-156} }